| For: | Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 2014; 20(12): 3255-3264 [PMID: 24695798 DOI: 10.3748/wjg.v20.i12.3255] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3255.htm |
| Number | Citing Articles |
| 1 |
Michael R. Tom, Ji Li, Aito Ueno, Miriam Fort Gasia, Ronald Chan, Daniel Y. Hung, Shem Chenoo, Marietta Iacucci, Humberto B. Jijon, Gilaad G. Kaplan, Paul L. Beck, Remo Panaccione, Herman W. Barkema, Andre G. Buret, Vijay Yajnik, Subrata Ghosh. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(7) doi: 10.1097/MIB.0000000000000848
|
| 2 |
Rafael Gil-Borras, Carlos García-Ballesteros, Carmen Benet-Campos, Ignacio Catalán-Serra, Francisca López-Chuliá, Carmen Cuéllar, Juan Carlos Andreu-Ballester. B1a Lymphocytes (CD19+CD5+) Deficiency in Patients with Crohn’s Disease and Its Relation with Disease Severity. Digestive Diseases 2018; 36(3) doi: 10.1159/000486893
|
| 3 |
Yue Li, Yayue Zhang, Xuran Ding, Taotao Zou, Hu Li, Ke Xu, Cheng Su, Yuting Wang, Ziming Zhao, Yuan He. Tailored platelet biomimetic delivery platform for targeted therapy of inflammatory bowel disease. Chemical Engineering Journal 2025; 520 doi: 10.1016/j.cej.2025.166357
|
| 4 |
Jongyoon Shinn, Juyeon Lee, Seon Ah Lee, Seon Ju Lee, Ah Hyun Choi, Jung Seo Kim, Su Jin Kim, Hyo Jin Kim, Cherin Lee, Yejin Kim, Joohyeon Kim, Jonghee Choi, Byungchae Jung, Taeho Kim, HyeonTaek Nam, Hyungjun Kim, Yonghyun Lee. Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease. Pharmaceutics 2022; 14(9) doi: 10.3390/pharmaceutics14091969
|
| 5 |
Chin‐Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Eun Hye Kim, Sungchan Ha, Eun Shin, Hoon Choi, Kyu‐Won Kim, Sejin Jeon, Goo Taeg Oh, Yeong‐Jae Seok. Ninjurin1 deficiency differentially mitigates colorectal cancer induced by azoxymethane and dextran sulfate sodium in male and female mice. International Journal of Cancer 2025; 156(4) doi: 10.1002/ijc.35225
|
| 6 |
Yanhong Lin, Yanping Zhang, Xiaojun Wang, Ya Wang, Aiqing Zhang. YTHDF1 Drives Ferroptosis in Ulcerative Colitis via m6A‐ACSL4 Stabilization. APMIS 2026; 134(1) doi: 10.1111/apm.70107
|
| 7 |
Karthik Gnanapandithan, Laura G. Stuessel, Bo Shen, Fadi H. Mourad, Zhongwei Peng, Francis A. Farraye, Jana G. Hashash. Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch. Digestive Diseases and Sciences 2024; 69(9) doi: 10.1007/s10620-024-08576-6
|
| 8 |
Marjolein van Egmond, Gestur Vidarsson, Jantine E. Bakema. Cross‐talk between pathogen recognizing Toll‐like receptors and immunoglobulin Fc receptors in immunity. Immunological Reviews 2015; 268(1) doi: 10.1111/imr.12333
|
| 9 |
Belal Chami, Patrick T. San Gabriel, Stephen Kum-Jew, XiaoSuo Wang, Nina Dickerhof, Joanne M. Dennis, Paul K. Witting. The nitroxide 4-methoxy-tempo inhibits the pathogenesis of dextran sodium sulfate-stimulated experimental colitis. Redox Biology 2020; 28 doi: 10.1016/j.redox.2019.101333
|
| 10 |
Xiaoyu Yang, Jinjian Xu, Hong Ji, Jun Li, Bingqing Yang, Liye Wang. Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1508455
|
| 11 |
Jihui WANG, Xiangyu CHEN, Han WANG, Shan XIAO, Bo WANG, Yanxue CAI. Effects of catalpa seed oil and pomegranate seed oil on body weight and intestinal flora in mice. Food Science and Technology 2022; 42 doi: 10.1590/fst.85622
|
| 12 |
Ni Guo, Lu‐lu Lv. Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis. Immunity, Inflammation and Disease 2023; 11(10) doi: 10.1002/iid3.1045
|
| 13 |
Nooshin Mohebali, Markus Weigel, Torsten Hain, Mona Sütel, Jana Bull, Bernd Kreikemeyer, Anne Breitrück. Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg/Th17 cell balance and intestinal barrier integrity. Biomedicine & Pharmacotherapy 2023; 167 doi: 10.1016/j.biopha.2023.115568
|
| 14 |
Stephanie Stras, Lael Warner, Jessica Toothaker, Austin Oldham, Oluwabunmi Olaloye, Yu Nee Lee, Erez Rechavi, Dror S. Shouval, Liza Konnikova. Priming and Maturation of the Human Fetal Mucosal Immunity Occurs Early in Fetal Development. SSRN Electronic Journal 2019; doi: 10.2139/ssrn.3323375
|
| 15 |
Kanika Suri, Jason A. Bubier, Michael V. Wiles, Leonard D. Shultz, Mansoor M. Amiji, Vishnu Hosur. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021; 10(9) doi: 10.3390/cells10092204
|
| 16 |
Mousumi Mandal, Ahmed Rakib, Md Abdullah Al Mamun, Santosh Kumar, Frank Park, Dong-Jin Hwang, Wei Li, Duane D. Miller, Udai P. Singh. DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis. Biomedicine & Pharmacotherapy 2024; 179 doi: 10.1016/j.biopha.2024.117379
|
| 17 |
Noah C. Wilson, Danielle B. Dilsaver, Ryan W. Walters, Kalyana C. Nandipati. Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database. Obesity Surgery 2024; 34(4) doi: 10.1007/s11695-024-07111-w
|
| 18 |
Sicheng Zhang, Duane D. Miller, Wei Li. Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22042128
|
| 19 |
Zhengzheng Wang, Shan Li, Qi Tan, Jianmin Sang, Zhen Xu, Xuewei Ding, Xiaoyan Yao, Nianzhen Chen, Shanshan Yu, Ming Zong, Ying Lu, Lan Zhong, Lieying Fan. SIRL-1 deficiency reveals pro-inflammatory IL-8 axis in inflammatory bowel disease: a novel diagnostic ratio. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1805306
|
| 20 |
Yaroslav Ugolkov, Antonina Nikitich, Cristina Leon, Gabriel Helmlinger, Kirill Peskov, Victor Sokolov, Alina Volkova. Mathematical modeling in autoimmune diseases: from theory to clinical application. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1371620
|
| 21 |
Tanya Kadiyska, Ivan Tourtourikov, Ana-Maria Popmihaylova, Hilda Kadian, Ani Chavoushian. Role of <i>TNFSF15</i> in the intestinal inflammatory response. World Journal of Gastrointestinal Pathophysiology 2018; 9(4): 73-78 doi: 10.4291/wjgp.v9.i4.73
|
| 22 |
Xiaona Yang, Hong Guo, Min Zou. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-025-00395-z
|
| 23 |
Chloé Michaudel, Camille Danne, Allison Agus, Aurélie Magniez, Anne Aucouturier, Madeleine Spatz, Antoine Lefevre, Julien Kirchgesner, Nathalie Rolhion, Yazhou Wang, Aonghus Lavelle, Chloé Galbert, Gregory Da Costa, Maxime Poirier, Alexia Lapière, Julien Planchais, Petr Nádvorník, Peter Illes, Cyriane Oeuvray, Laura Creusot, Marie-Laure Michel, Nicolas Benech, Anne Bourrier, Isabelle Nion-Larmurier, Cecilia Landman, Mathias L Richard, Patrick Emond, Philippe Seksik, Laurent Beaugerie, Rafael Rose Arguello, David Moulin, Sridhar Mani, Zdenek Dvorák, Luis G Bermúdez-Humarán, Philippe Langella, Harry Sokol. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut 2023; 72(7) doi: 10.1136/gutjnl-2022-327337
|
| 24 |
Jessica Nguyen, Brian S. Finkelman, David Escobar, Yue Xue, Kristy Wolniak, Maryam Pezhouh. Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease. Human Pathology 2022; 126 doi: 10.1016/j.humpath.2022.04.011
|
| 25 |
Grace E. Hey, Vinata Vedam-Mai, Matthew Beke, Manuel Amaris, Adolfo Ramirez-Zamora. The Interface between Inflammatory Bowel Disease, Neuroinflammation, and Neurological Disorders. Seminars in Neurology 2023; 43(04) doi: 10.1055/s-0043-1771467
|
| 26 |
G. V. Volynets, A. V. Nikitin, T. A. Skvortsova, A. S. Potapov, V. V. Dudurich, L. G. Danilov, V. S. Kokiashvili. Gut microbiota in autoimmune and non-autoimmune liver diseases in children. Experimental and Clinical Gastroenterology 2024; (7) doi: 10.31146/1682-8658-ecg-215-7-25-33
|
| 27 |
Xuanyi Yang, Xumin Zhao, Guanghui Wang, Xiaohui Dong, Qihui Yang, Hongyu Liu, Shuang Zhang, Beiping Tan, Shuyan Chi. Improvement of hybrid grouper (Epinephelus fuscoguttatus ♀ × E. lanceolatus ♂) by enzyme-digested poultry by-product: Growth performance, amino acid and peptide transport capacity, and intestinal morphology. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.955734
|
| 28 |
Miriam Y. Walker, Siddharth Pratap, Janet H. Southerland, Cherae M. Farmer-Dixon, Kesavalu Lakshmyya, Pandu R. Gangula. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 2018; 73 doi: 10.1016/j.niox.2017.06.003
|
| 29 |
Jiaxin Zhang, Yuge Zhao, Tianling Hou, Hairong Zeng, Dipika Kalambhe, Bing Wang, Xiaoyan Shen, Yongzhuo Huang. Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 2020; 320 doi: 10.1016/j.jconrel.2020.01.047
|
| 30 |
Egil Johnson, Stig Palm Therkelsen, Ivo Nentwich, Lise Sofie Haug Nissen-Meyer, Geir Hetland. IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway. Scandinavian Journal of Gastroenterology 2019; 54(9) doi: 10.1080/00365521.2019.1663445
|
| 31 |
Eva Latorre, Elena Layunta, Laura Grasa, Julián Pardo, Santiago García, Ana I Alcalde, José E Mesonero. Toll-like receptors 2 and 4 modulate intestinal IL-10 differently in ileum and colon. United European Gastroenterology Journal 2018; 6(3) doi: 10.1177/2050640617727180
|
| 32 |
Bani Ahluwalia, Luiza Moraes, Maria K. Magnusson, Lena Öhman. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scandinavian Journal of Gastroenterology 2018; 53(4) doi: 10.1080/00365521.2018.1447597
|
| 33 |
Mingqiang Wang, Yanzhen Li, Jianhui Su, Jingyan Bai, Zhongxiang Zhao, Zhanghua Sun. Protective effects of 4‐geranyloxy‐2,6‐dihydroxybenzophenonel on DSS‐induced ulcerative colitis in mice via regulation of cAMP/PKA/CREB and NF‐κB signaling pathways. Phytotherapy Research 2023; 37(4) doi: 10.1002/ptr.7689
|
| 34 |
Yue Li, Helen Ka Wai Law. Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1070184
|
| 35 |
Min Chen, Huanrong Lan, Ketao Jin, Yun Chen. Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives. Drug Delivery 2023; 30(1) doi: 10.1080/10717544.2023.2219427
|
| 36 |
Aleksandra Korta, Julia Kula, Krzysztof Gomułka. The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210172
|
| 37 |
Rui Lin, Meiyu Piao, Yan Song. Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in Citrobacter rodentium-Infected Mice. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01092
|
| 38 |
Heng Li, Chen Fan, Chunlan Feng, Yanwei Wu, Huimin Lu, Peilan He, Xiaoqian Yang, Fenghua Zhu, Qing Qi, Yuanzhuo Gao, Jianping Zuo, Wei Tang. Inhibition of phosphodiesterase‐4 attenuates murine ulcerative colitis through interference with mucosal immunity. British Journal of Pharmacology 2019; 176(13) doi: 10.1111/bph.14667
|
| 39 |
Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu. Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions. Interdisciplinary Medicine 2026; 4(1) doi: 10.1002/inmd.70083
|
| 40 |
Tapan Bhavsar. Precision Molecular Pathology of Aggressive B-Cell Lymphomas. Molecular Pathology Library 2023; doi: 10.1007/978-3-031-46842-1_24
|
| 41 |
A. Quesada-Simó, A. Garrido-Marín, P. Nos, S. Gil-Perotín. Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1186016
|
| 42 |
Yava L. Jones-Hall, Cindy H. Nakatsu. The Intersection of TNF, IBD and the Microbiome. Gut Microbes 2016; 7(1) doi: 10.1080/19490976.2015.1121364
|
| 43 |
Stephanie F. Stras, Lael Werner, Jessica M. Toothaker, Oluwabunmi O. Olaloye, Austin L. Oldham, Collin C. McCourt, Yu Nee Lee, Erez Rechavi, Dror S. Shouval, Liza Konnikova. Maturation of the Human Intestinal Immune System Occurs Early in Fetal Development. Developmental Cell 2019; 51(3) doi: 10.1016/j.devcel.2019.09.008
|
| 44 |
Yuxiao Liao, Zhao Peng, Liangkai Chen, Andreas K. Nüssler, Liegang Liu, Wei Yang. Deoxynivalenol, gut microbiota and immunotoxicity: A potential approach?. Food and Chemical Toxicology 2018; 112 doi: 10.1016/j.fct.2018.01.013
|
| 45 |
Nuradilla Mohamad-Fauzi, Claire Shaw, Soraya H. Foutouhi, Matthias Hess, Nguyet Kong, Amir Kol, Dylan Bobby Storey, Prerak T. Desai, Jigna Shah, Dori Borjesson, James D. Murray, Bart C. Weimer. Salmonella enhances osteogenic differentiation in adipose-derived mesenchymal stem cells. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1077350
|
| 46 |
Mabrouka Salem, Joanna Lecka, Julie Pelletier, Danielle Gomes Marconato, Aline Dumas, Luc Vallières, Gaetan Brochu, Bernard Robaye, Christian Jobin, Jean Sévigny. NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD. Gut 2022; 71(1) doi: 10.1136/gutjnl-2020-320937
|
| 47 |
Andrew Blauvelt, Andrea Chiricozzi. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clinical Reviews in Allergy & Immunology 2018; 55(3) doi: 10.1007/s12016-018-8702-3
|
| 48 |
Pichet Praveschotinunt, Anna M. Duraj-Thatte, Ilia Gelfat, Franziska Bahl, David B. Chou, Neel S. Joshi. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-13336-6
|
| 49 |
Burcu Aydinli Kazalak, Sibel Yaman, Mehmet Faik Ozcelik, Gozde Erkanli Senturk, Rahime Aydinli, Belisa Kaleci, Hafize Uzun. Protective Effects of Oxytocin on Experimental Colitis: Modulation of Cytokines, Oxidative Stress, and Caspase-3 Activity. Medicina 2026; 62(5) doi: 10.3390/medicina62050893
|
| 50 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25136935
|
| 51 |
Chhabi Lal Chaudhary, Pallavi Gurung, Seoul Jang, Suhrid Banskota, Tae-Gyu Nam, Jung-Ae Kim, Byeong-Seon Jeong. Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease. Journal of Enzyme Inhibition and Medicinal Chemistry 2020; 35(1) doi: 10.1080/14756366.2019.1677637
|
| 52 |
Pingping Li, Junxiu Shi, Peng Zhang, Ke Wang, Jinglong Li, Hongju Liu, Yu Zhou, Xi Xu, Jie Hao, Xiuyuan Sun, Xuewen Pang, Yan Li, Hounan Wu, Xiaoping Chen, Qing Ge. Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility. The FASEB Journal 2015; 29(8) doi: 10.1096/fj.15-271700
|
| 53 |
Xinyang Chen, Qiqiong Li, Wanyu Zhang, Yushan Xu, Xinke Nie, Xindong Wang, Chunhua Chen, Junhua Xie, Shaoping Nie.
Akkermansia muciniphila-
derived extracellular vesicles alleviate colitis-related cognitive impairment via tryptophan metabolic reprogramming of the gut‒brain axis
. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2025.2611546
|
| 54 |
Non-coding RNAs: Emerging biomarkers and therapeutic targets in ulcerative colitis. Pathology - Research and Practice 2024; 253 doi: 10.1016/j.prp.2023.155037
|
| 55 |
Priscilla Clímaco Rebouças, João Gomes Netinho, Geni Satomi Cunrath, Luiz Sergio Ronchi, Marcelo Maia Caixeta de Melo, Francisco de Assis Gonçalves Filho, Rafaela Cristina Coelho Muniz, Alissonn Teixeira Silva Martins, Rafael Andrade de Oliveira, Ricardo Mendonça Costa Junior. Hypovitaminosis D in patients with Crohn's disease. Journal of Coloproctology 2016; 36(02) doi: 10.1016/j.jcol.2016.03.001
|
| 56 |
Arshia Shahini, Ali Shahini. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome. Journal of Cell Communication and Signaling 2023; 17(1) doi: 10.1007/s12079-022-00695-x
|
| 57 |
Su-Jeong Oh, Yoojin Seo, Ji-Su Ahn, Ye Young Shin, Ji Won Yang, Hyoung Kyu Kim, Jin Han, Natalia P. Mishchenko, Sergey A. Fedoreyev, Valentin A. Stonik, Hyung-Sik Kim. Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells. Marine Drugs 2019; 17(11) doi: 10.3390/md17110622
|
| 58 |
Kiana Mortezaei, Sofia Audrey B. Gonzales, Adam Kreitenberg, Daniel G. Arkfeld. Scurvy in a Patient with Crohn’s Disease: A Case Report. Current Rheumatology Reviews 2026; 22(2) doi: 10.2174/0115733971355926250805052920
|
| 59 |
Ayushi Mairal, Shreya Mehrotra, Anupam Kumar, Rakhi Maiwal, Jan Marsal, Ashok Kumar. Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device. ACS Applied Materials & Interfaces 2024; 16(5) doi: 10.1021/acsami.3c14113
|
| 60 |
Yi-Chih Chang, Yung-Hao Ching, Chien-Chao Chiu, Ju-Yun Liu, Shao-Wen Hung, Wen-Ching Huang, Yen-Te Huang, Hsiao-Li Chuang, Mathias Chamaillard. TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0180025
|
| 61 |
Haddad S, Perrotta G, Pezzullo M, Franchimont D, Elands S. Colitis and pancreatitis following ocrelizumab therapy for multiple sclerosis: a report of two cases. Neuroimmunology Reports 2026; 9 doi: 10.1016/j.nerep.2026.100279
|
| 62 |
Triet M. Bui, Lorraine A. Mascarenhas, Ronen Sumagin. Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair. Tissue Barriers 2018; 6(2) doi: 10.1080/21688370.2018.1431038
|
| 63 |
Juan Wang, Huiying Gao, Yuan Xie, Peng Wang, Yu Li, Junli Zhao, Chunlin Wang, Xin Ma, Yuwen Wang, Qinwen Mao, Haibin Xia. Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1044576
|
| 64 |
Ling Qin, Zhi-qiang Yao, Qi Chang, Ya-li Zhao, Ning-ning Liu, Xiao-shan Zhu, Qin-qin Liu, Li-feng Wang, An-gang Yang, Chun-fang Gao, Jun-tang Li. Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis. Oncotarget 2017; 8(5) doi: 10.18632/oncotarget.14080
|
| 65 |
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
|
| 66 |
Jinting Li, Yunmei Mu, Yiwei Liu, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama. Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis. Polymers 2021; 13(9) doi: 10.3390/polym13091472
|
| 67 |
Diego Montoya-Cerrillo, Anas Bernieh, Ali G. Saad. Critical diagnoses in paediatric gastrointestinal diseases. Pathology 2022; 54(2) doi: 10.1016/j.pathol.2021.09.023
|
| 68 |
Vicente Pérez-Brocal, Rodrigo García-López, Pilar Nos, Belén Beltrán, Inés Moret, Andrés Moya. Metagenomic Analysis of Crohnʼs Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers. Inflammatory Bowel Diseases 2015; 21(11) doi: 10.1097/MIB.0000000000000549
|
| 69 |
T. H. Ho, B. L. Cohen, J.-F. Colombel, S. Mehandru. Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy. Alimentary Pharmacology & Therapeutics 2014; 40(10) doi: 10.1111/apt.12976
|
| 70 |
Valentina P. Sebastián, Geraldyne A. Salazar, Irenice Coronado-Arrázola, Bárbara M. Schultz, Omar P. Vallejos, Loni Berkowitz, Manuel M. Álvarez-Lobos, Claudia A. Riedel, Alexis M. Kalergis, Susan M. Bueno. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01956
|
| 71 |
María-José Fábrega, Alba Rodríguez-Nogales, José Garrido-Mesa, Francesca Algieri, Josefa Badía, Rosa Giménez, Julio Gálvez, Laura Baldomà. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01274
|
| 72 |
Premal Vaghela, Bhavarth Dave, Akshada Dabhade, Rohitas Deshmukh, Bhupendra Prajapati, Omar Awad Alsaidan, Suhaskumar Patel, Ankush Mehta, Anup Singh, Kiran Dudhat. Redrawing the gut map: evolving probiotic approaches to microbiota modulation in inflammatory bowel disease. Antonie van Leeuwenhoek 2026; 119(3) doi: 10.1007/s10482-026-02254-5
|
| 73 |
Waseem Khalid, Muhammad Sajid Arshad, Muhammad Modassar Ali Nawaz Ranjha, Maria Barbara Różańska, Shafeeqa Irfan, Bakhtawar Shafique, Muhammad Abdul Rahim, Muhammad Zubair Khalid, Gholamreza Abdi, Przemysław Łukasz Kowalczewski. Functional constituents of plant-based foods boost immunity against acute and chronic disorders. Open Life Sciences 2022; 17(1) doi: 10.1515/biol-2022-0104
|
| 74 |
Vytautas Kiudelis, Greta Gedgaudienė, Justina Veličkienė, Dalius Petrauskas, Jurgita Skiecevičienė, Juozas Kupčinskas, Gediminas Kiudelis, Laimas Virginijus Jonaitis. Plasma FABP2, IL-10, and LPS in Microscopic Colitis: An Exploratory Study of Their Biomarker Potential. Medicina 2026; 62(7) doi: 10.3390/medicina62071237
|
| 75 |
Ren‐Xiao Wang, Mi Zhou, Hui‐Lai Ma, Yuan‐Biao Qiao, Qing‐Shan Li. The Role of Chronic Inflammation in Various Diseases and Anti‐inflammatory Therapies Containing Natural Products. ChemMedChem 2021; 16(10) doi: 10.1002/cmdc.202000996
|
| 76 |
Hui Li, Shuangshuang Chen, Yumei Li, Zelin Sang, Zhenhua Chen, Xifan Mei, Xiuli Ren. Preparation of gastrointestinal pH-responsive zein coated tea polyphenol-heparin hydrocolloids using for inflammatory bowel disease therapy. International Journal of Biological Macromolecules 2025; 309 doi: 10.1016/j.ijbiomac.2025.143135
|
| 77 |
Xiaojie Yu, Xiaobin Chen, Tiansheng Sun. MicroRNA-205-5p Targets HMGB1 to Suppress Inflammatory Responses during Lung Injury after Hip Fracture. BioMed Research International 2019; 2019 doi: 10.1155/2019/7304895
|
| 78 |
Sally E. Abu-Risha, Nageh A. El-Mahdy, Fatma T. El-Hosiny, Mayada E. Elhusseiny, Aya H. El-Kadem. Anticolitis effect of febuxostat. The imperative role of NLRP-3/Caspase-1/IL-1β pathway via histopathological, immunohistochemical and biochemical approach. Immunopharmacology and Immunotoxicology 2025; 47(5) doi: 10.1080/08923973.2025.2542136
|
| 79 |
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh. Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2024.00044
|
| 80 |
The Microbiome in Health and Disease. Progress in Molecular Biology and Translational Science 2020; 171 doi: 10.1016/bs.pmbts.2020.03.007
|
| 81 |
Dov Wengrower, Benjamin Koslowsky, Uri Peleg, Betty Mazuz, Leore Cohen, Allin Ben-David, Menahem Gross, Eran Goldin, Chanan Shaul. Hearing Loss in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2016; 61(7) doi: 10.1007/s10620-016-4074-9
|
| 82 |
Neil R Moran, Bradley Webster, Kenneth M Lee, Judith Trotman, Yiu-Lam Kwan, John Napoli, Rupert W Leong. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn’s disease. World Journal of Gastroenterology 2015; 21(19): 6072-6076 doi: 10.3748/wjg.v21.i19.6072
|
| 83 |
Reem M Alqahtani, Aseel Alghanemi, Abdulrahman M Aljifri, Ibraheem M Ghulman, Saif Y Ashram, Essam A Alghamdi, Abdulrahman E Azhar, Ziad A Ibrahim, Meshal M Alsudais, Abdulaziz W Banaja. Public Knowledge of Inflammatory Bowel Diseases in Saudi Arabia: A Cross-Sectional Survey Study. Cureus 2023; doi: 10.7759/cureus.40114
|
| 84 |
Caroline Klotz, Maximilien Barret, Marion Dhooge, Ammar Oudjit, Stanislas Chaussade, Romain Coriat, Vered Abitbol. Rectocolite hémorragique : conduite diagnostique et prise en charge thérapeutique. La Presse Médicale 2015; 44(2) doi: 10.1016/j.lpm.2014.06.025
|
| 85 |
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi, Francesco Costa. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02621-7
|
| 86 |
Tanmoy Rana. Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022; 28(8) doi: 10.1093/ibd/izac017
|
| 87 |
Pedro M. Veloso, Raul Machado, Clarisse Nobre. Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2021; 167 doi: 10.1016/j.ejpb.2021.07.014
|
| 88 |
Jesus E. Juarez, Tahmineh Romero, Constantine A. Mantz, Abigail Pepin, Nima Aghdam, Simeng Suy, Michael L. Steinberg, Rebecca G. Levin-Epstein, Nicholas G. Nickols, Irving D. Kaplan, Robert M. Meier, Huong T. Pham, Patrick W. Linson, Robert L. Hong, Mark K. Buyyounouski, Hilary P. Bagshaw, Donald B. Fuller, Alan J. Katz, Andrew Loblaw, Sean P. Collins, Amar U. Kishan. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. Advances in Radiation Oncology 2021; 6(6) doi: 10.1016/j.adro.2021.100759
|
| 89 |
Gal Cohen, Ofer Gover, Betty Schwartz. Phytocannabinoids Reduce Inflammation of Primed Macrophages and Enteric Glial Cells: An In Vitro Study. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914628
|
| 90 |
Yufei Yang, Lijun Xu, Yuqi Qiao, Tianrong Wang, Qing Zheng. Construction of a neural network diagnostic model and investigation of immune infiltration characteristics for Crohn’s disease. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.976578
|
| 91 |
A. Fernandes, P.M. Rodrigues, M. Pintado, F.K. Tavaria. A systematic review of natural products for skin applications: Targeting inflammation, wound healing, and photo-aging. Phytomedicine 2023; 115 doi: 10.1016/j.phymed.2023.154824
|
| 92 |
Federica Furfaro, Ludovico Alfarone, Daniela Gilardi, Carmen Correale, Mariangela Allocca, Gionata Fiorino, Marjorie Argollo, Alessandra Zilli, Eirini Zacharopoulou, Laura Loy, Giulia Roda, Silvio Danese. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease. Current Drug Targets 2021; 22(7) doi: 10.2174/1389450122999210120205607
|
| 93 |
Ki Jae Jo, Jong Pil Im. Beyond the survey, to the ideal therapy for Asian. Intestinal Research 2023; 21(3) doi: 10.5217/ir.2023.00075
|
| 94 |
Chongkang Yue, Huiping Xue. Identification and immune landscape of sarcopenia-related molecular clusters in inflammatory bowel disease by machine learning and integrated bioinformatics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68198-w
|
| 95 |
Peter M Irving, Simon de Lusignan, Daniel Tang, Monica Nijher, Kevin Barrett. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterology 2021; 8(1) doi: 10.1136/bmjgast-2020-000573
|
| 96 |
Sun-Ho Kwon, Eun-Bi Seo, Song-Hee Lee, Chung-Hyun Cho, Sung Joon Kim, Sang Jeong Kim, Hang-Rae Kim, Sang-Kyu Ye. T Cell-Specific Knockout of STAT3 Ameliorates Dextran Sulfate Sodium-Induced Colitis by Reducing the Inflammatory Response. Immune Network 2018; 18(4) doi: 10.4110/in.2018.18.e30
|
| 97 |
Jung Sik Lim, Chae Rim Kim, Kwang Soon Shin, Hee Jung Park, Taek Joon Yoon. Red Ginseng Extract and γ-Aminobutyric Acid Synergistically Enhance Immunity Against Cancer Cells and Antitumor Metastasis Activity in Mice. Journal of Medicinal Food 2023; 26(1) doi: 10.1089/jmf.2022.K.0079
|
| 98 |
Wenbo Jiang, Yiding Geng, Bai Li, Conghui Qiao, Zijie Liu, Xinyu Shan, Xinyang Wang, Wei Wei, Tianshu Han. Inadequate Zinc Intake in Adolescents Aggravates Inflammatory Bowel Disease by Inhibiting Antibody Class Switch Recombination in Mucosal B Cells Through Intestinal Microbial‐Derived KMV. iMetaMed 2026; 2(1) doi: 10.1002/imm3.70031
|
| 99 |
L. Puig. Psoriasis, artritis psoriásica y enfermedad de Crohn: circuitos de citocinas y papel de la disbiosis. Actas Dermo-Sifiliográficas 2016; 107(2) doi: 10.1016/j.ad.2015.09.008
|
| 100 |
Yichi Zhang, Nijina Li, Dan Zhang, Hao Zhang. WTAP-mediated m6A modification of PTPN1 contributes to ulcerative colitis pathogenesis through regulating colonic epithelial cell phenotypes. Human Cell 2025; 39(1) doi: 10.1007/s13577-025-01307-7
|
| 101 |
Kai-hong Zang, Hong-yan Qin, Hai-Jing Duan, Qing-lin Ma, Yuan Ren. Astragaloside IV Attenuates Trinitrobenzene Sulphonic Acid (TNBS)-Induced Colitis via Improving Mucosal Barrier Function: Role of Goblet Cells. International Journal of Pharmacology 2018; 14(8) doi: 10.3923/ijp.2018.1160.1168
|
| 102 |
Heba A. Mahmoud, Wesam M. Salama, Reham A. Mariah, Asmaa M. Eid. Ameliorative effect of Leiurus quinquestriatus venom on acetic acid-induced colitis in mice. Scientific African 2021; 14 doi: 10.1016/j.sciaf.2021.e01009
|
| 103 |
Xueling He, Jiayan Liu, Guohao Long, Xin-Hua Xia, Mei Liu. 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota. Biomedicine & Pharmacotherapy 2021; 137 doi: 10.1016/j.biopha.2021.111420
|
| 104 |
Wenjing Zhu, Qian Cheng, Chang Liu, Jiacheng Qian, Jia Xu, Xinyuan Wang. LTr1 alleviates DSS-induced ulcerative colitis by modulating macrophages to inhibit M1 polarization and associated inflammatory responses. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1651922
|
| 105 |
Seow-Neng Chan, Eden Ngah Den Low, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intestinal Research 2018; 16(3) doi: 10.5217/ir.2018.16.3.374
|
| 106 |
Md Abdullah Al Mamun, Ahmed Rakib, Mousumi Mandal, Santosh Kumar, Bhupesh Singla, Udai P. Singh. Polyphenols: Role in Modulating Immune Function and Obesity. Biomolecules 2024; 14(2) doi: 10.3390/biom14020221
|
| 107 |
Jingqi Zhao, Ting Yan, Yaqi Wang, Yanrui Yang, Weitao Geng, Jinju Wang, Longgang Jia, Yanping Wang. Lactobacillus plantarum BC299 can alleviate dextran sulphate sodium‐induced colitis by regulating immune response and modulating gut microbiota. International Journal of Food Science & Technology 2021; 56(11) doi: 10.1111/ijfs.15207
|
| 108 |
Luca Antonioli, Maria Cecilia Giron, Rocchina Colucci, Carolina Pellegrini, Deborah Sacco, Valentina Caputi, Genny Orso, Marco Tuccori, Carmelo Scarpignato, Corrado Blandizzi, Matteo Fornai, Jean Kanellopoulos. Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats. PLoS ONE 2014; 9(12) doi: 10.1371/journal.pone.0116253
|
| 109 |
Gabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Erika Miguel-Cruz, Rafel Barreto-Zuñiga, Braulio Martínez-Benítez, Jesus K. Yamamoto-Furusho. Protective role of ABCC drug subfamily resistance transporters (ABCC1-7) in intestinal inflammation. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-024-09583-5
|
| 110 |
Özen Taş, Fatma Aydın, Zarife Kuloğlu, Ceyda Tuna Kırsaçlıoğlu, Onur Bahçeci, Betül Öksüz Aydın, Doğacan Sarısoy, Zeynep Birsin Özçakar. Inflammatory bowel disease in paediatric rheumatological diseases. Clinical Rheumatology 2025; 44(5) doi: 10.1007/s10067-025-07424-w
|
| 111 |
Jean Carlos Fernando Besson, Caroline de Carvalho Picoli, Graciette Matioli, Maria Raquel Marçal Natali. Methyl jasmonate: a phytohormone with potential for the treatment of inflammatory bowel diseases. Journal of Pharmacy and Pharmacology 2018; 70(2) doi: 10.1111/jphp.12839
|
| 112 |
Nageh Ahmed El-Mahdy, Dina Ali Saleh, Magdy Salah Amer, Sally El-Sayed Abu-Risha. Role of allopurinol and febuxostat in the amelioration of dextran-induced colitis in rats. European Journal of Pharmaceutical Sciences 2020; 141 doi: 10.1016/j.ejps.2019.105116
|
| 113 |
Xiong Sun, Yao Huang, Ya-Li Zhang, Dan Qiao, Yan-Cheng Dai. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World Journal of Gastroenterology 2020; 26(48): 7593-7602 doi: 10.3748/wjg.v26.i48.7593
|
| 114 |
Noah Becher, Arun Swaminath, Keith Sultan. A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application. Therapeutics and Clinical Risk Management 2022; doi: 10.2147/TCRM.S336139
|
| 115 |
Shimaa M. Elshazly, Ahmed E.M. Elhassanny, Nevertyty M. Mahmoud. Cilostazol protects against acetic acid-induced colitis in rats: Possible role for cAMP/SIRT1 pathway. European Journal of Pharmacology 2020; 881 doi: 10.1016/j.ejphar.2020.173234
|
| 116 |
L. Puig. Cytokine Pathways and the Role of Dysbiosis in Psoriasis, Psoriatic Arthritis, and Crohn Disease. Actas Dermo-Sifiliográficas (English Edition) 2016; 107(2) doi: 10.1016/j.adengl.2016.01.001
|
| 117 |
Maraisa Cristina Silva, Helioswilton Sales-Campos, Carlo José Freire Oliveira, Tamires Lopes Silva, Flávia Batista Ferreira França, Fábio Oliveira, Tiago Wilson Patriarca Mineo, José Roberto Mineo. Treatment with a Zinc Metalloprotease Purified from Bothrops moojeni Snake Venom (BmooMP-Alpha-I) Reduces the Inflammation in an Experimental Model of Dextran Sulfate Sodium-Induced Colitis. Mediators of Inflammation 2019; 2019 doi: 10.1155/2019/5195134
|
| 118 |
Heli Li, Qianru Li, Shiran Sun, Ping Lei, Xiong Cai, Guanxin Shen, Lihua Duan. Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn’s Disease. Journal of Immunology Research 2020; 2020(1) doi: 10.1155/2020/3067273
|
| 119 |
Amalia Di Petrillo, Amit Kumar, Sara Onali, Agnese Favale, Massimo Claudio Fantini. GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023; 29(12) doi: 10.1093/ibd/izad161
|
| 120 |
M Guzmán, I Keitelman, F Sabbione, A S Trevani, M N Giordano, J G Galletti. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease. Clinical and Experimental Immunology 2016; 184(2) doi: 10.1111/cei.12759
|
| 121 |
Kristen K. Lee, Bindia Jharap, Elena A. Maser, Jean-Frederic Colombel. Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(1) doi: 10.1097/MIB.0000000000000577
|
| 122 |
Amjad Ahmadi, Rasoul Yousefimashouf, Asadollah Mohammadi, Bahram Nikkhoo, Leili Shokoohizadeh, Mohammadali Khan Mirzaei, Mohammad Yousef Alikhani, Farshad Sheikhesmaili, Hakim Khodaei. Investigating the expression of anti/pro-inflammatory cytokines in the pathogenesis and treatment of ulcerative colitis and its association with serum level of vitamin D. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87551-1
|
| 123 |
Hyun Jin Jung, Ju-Hee Kang, Seongwon Pak, Keunwook Lee, Je Kyung Seong, Seung Hyun Oh. Detrimental Role of Nerve Injury-Induced Protein 1 in Myeloid Cells under Intestinal Inflammatory Conditions. International Journal of Molecular Sciences 2020; 21(2) doi: 10.3390/ijms21020614
|
| 124 |
Sonia Fonseca, Ana L. Carvalho, Ariadna Miquel-Clopés, Emily J. Jones, Rokas Juodeikis, Régis Stentz, Simon R. Carding. Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1050271
|
| 125 |
Bo Wang, Jie Yang, Lijun Tao, Xuebing Zhou, Xiaoling Ding. Structural-activity relationship of Lycium barbarum polysaccharides in immunomodulation: integrating molecular insights with target identification for therapeutic development. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1730418
|
| 126 |
Bjoern Titz, Raffaella M. Gadaleta, Giuseppe Lo Sasso, Ashraf Elamin, Kim Ekroos, Nikolai V. Ivanov, Manuel C. Peitsch, Julia Hoeng. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification. International Journal of Molecular Sciences 2018; 19(9) doi: 10.3390/ijms19092775
|
| 127 |
Chong Zhang, Fen Zeng, Zhengyang Fan, Zhen He, Liang Tai, Qiang Peng, Yixin Zhang, Zhenhua Chao, Wenning Jiang, Lingyun Jia, Lulu Han. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease. Acta Biomaterialia 2023; 169 doi: 10.1016/j.actbio.2023.08.020
|
| 128 |
Giuseppe Lo Sasso, Walter K. Schlage, Blaine Phillips, Manuel C. Peitsch, Julia Hoeng. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy. 2018; doi: 10.5772/intechopen.69569
|
| 129 |
Doha Anka Idrissi, Nezha Senhaji, Asmae Aouiss, Loubna Khalki, Youssef Tijani, Nabil Zaid, Fatima Zahra Marhoume, Abdallah Naya, Mounia Oudghiri, Mostafa Kabine, Younes Zaid. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targets. Archives of Pharmacal Research 2021; 44(1) doi: 10.1007/s12272-020-01296-1
|
| 130 |
Jehad Alzahrani, Tabinda Hussain, David Simar, Riya Palchaudhuri, Mohamed Abdel-Mohsen, Suzanne M. Crowe, George W. Mbogo, Clovis S. Palmer. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. eBioMedicine 2019; 46 doi: 10.1016/j.ebiom.2019.07.027
|
| 131 |
Luana Cagol, Teresa Seitel, Sarah Ehrenberg, Klara Frivolt, Andreas Krahl, Elke Lainka, Patrick Gerner, Henning Lenhartz, Jan Vermehren, Michael Radke, Stefan Trenkel, Benjamin Mayer, Sibylle Koletzko, Klaus-Michael Debatin, Thomas Mertens, Carsten Posovszky. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine 2020; 38(7) doi: 10.1016/j.vaccine.2019.12.024
|
| 132 |
Gurpreet Singh, Susie Brien, Ellen Taylor. A double conundrum: concurrent presentation of Hashimoto's thyroiditis and ulcerative colitis. BMJ Case Reports 2016; 2016 doi: 10.1136/bcr-2016-215185
|
| 133 |
Igor Rakoczy, Marzena Ocetek, Marzena Wiatr, Patrycja Zięba, Michał Panek, Piotr Kuna. NON–NECROTIZING INFLAMMATORY GRANULOMAS (N-NGS) IN THE COURSE OF INFLAMMATORY BOWEL DISEASE – IMMUNOLOGY AND CLINICAL MANIFESTATION OF INTESTINAL AND RESPIRATORY N-NGS. Wiadomości Lekarskie 2020; 73(7) doi: 10.36740/WLek202007143
|
| 134 |
Imene Soufli, Ryma Toumi, Hayet Rafa, Chafia Touil-Boukoffa. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(3): 353-360 doi: 10.4292/wjgpt.v7.i3.353
|
| 135 |
Cassie L. Rayner, Steven E. Bottle, Alexander P. Martyn, Nigel L. Barnett. Preserving Retinal Structure and Function with the Novel Nitroxide Antioxidant, DCTEIO. Neurochemical Research 2023; 48(11) doi: 10.1007/s11064-023-03978-w
|
| 136 |
Aicha Kriaa, Amin Jablaoui, Soufien Rhimi, Souha Soussou, Héla Mkaouar, Vincent Mariaule, Natalia Gruba, Ali Gargouri, Emmanuelle Maguin, Adam Lesner, Moez Rhimi. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice. Cells 2021; 10(10) doi: 10.3390/cells10102658
|
| 137 |
Ya-Hui Ma, Jie Zhang, Xue Chen, You-Fu Xie, Yan-Hua Pang, Xin-Juan Liu. Increased CD4<sup>+</sup>CD45RA<sup>-</sup>FoxP3<sup>low</sup> cells alter the balance between Treg and Th17 cells in colitis mice. World Journal of Gastroenterology 2016; 22(42): 9356-9367 doi: 10.3748/wjg.v22.i42.9356
|
| 138 |
Dong Lu, Bin Lan, Zonren Din, Hang Chen, Guoqiang Chen. A vitamin D receptor agonist converts CD4+ T cells to Foxp3+ regulatory T cells in patients with ulcerative colitis. Oncotarget 2017; 8(32) doi: 10.18632/oncotarget.18614
|
| 139 |
Ariadni Tzaneti, Elli Athanasopoulou, Smaragdi Fessatou, Lampros Fotis. Chronic Nonbacterial Osteomyelitis in Inflammatory Bowel Disease. Life 2023; 13(12) doi: 10.3390/life13122347
|
| 140 |
Ana Cardoso, Antonio Gil Castro, Ana Catarina Martins, Guilhermina M. Carriche, Valentine Murigneux, Isabel Castro, Ana Cumano, Paulo Vieira, Margarida Saraiva. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00400
|
| 141 |
Helioswilton Sales-Campos, Patricia Reis de Souza, Paulo José Basso, Anderson Daniel Ramos, Viviani Nardini, Javier Emílio Lazo Chica, Margareth Lara Capurro, Anderson Sá-Nunes, Cristina Ribeiro de Barros Cardoso. Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease. International Immunopharmacology 2015; 26(1) doi: 10.1016/j.intimp.2015.03.002
|
| 142 |
Audrey I. S. Andersen-Civil, Pankaj Arora, Andrew R. Williams. Regulation of Enteric Infection and Immunity by Dietary Proanthocyanidins. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.637603
|
| 143 |
Line R. Jølving, Jan Nielsen, Signe S. Beck-Nielsen, Rasmus G. Nielsen, Sonia Friedman, Ulrik S. Kesmodel, Bente M. Nørgård. The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children—A Nationwide Cohort Study. Inflammatory Bowel Diseases 2017; 23(8) doi: 10.1097/MIB.0000000000001146
|
| 144 |
Gaurav Agrawal, Thomas J. Borody, John M. Aitken. Mapping Crohn’s Disease Pathogenesis with Mycobacterium paratuberculosis: A Hijacking by a Stealth Pathogen. Digestive Diseases and Sciences 2024; 69(7) doi: 10.1007/s10620-024-08508-4
|
| 145 |
Vittorio Viti, Chiara Zanetta, Ruggero Capra, Andrea Municchi, Maria A. Rocca, Massimo Filippi. Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue. Journal of Neurology 2024; 271(9) doi: 10.1007/s00415-024-12553-4
|
| 146 |
Ruijuan Dong, Ming Bai, Jin Zhao, Di Wang, Xiaoxuan Ning, Shiren Sun. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.557368
|
| 147 |
Kenneth Prudence Abasubong, Ndakalimwe Naftal Gabriel, Jean-Jacques Yao Adjoumani. Emerging Sustainable Aquaculture Innovations in Africa. Sustainability Sciences in Asia and Africa 2023; doi: 10.1007/978-981-19-7451-9_10
|
| 148 |
Nan Wang, Rui Kong, Wei Han, Wen Bao, Yihai Shi, LiPing Ye, Jie Lu. Honokiol alleviates ulcerative colitis by targeting PPAR-γ–TLR4–NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro. International Immunopharmacology 2022; 111 doi: 10.1016/j.intimp.2022.109058
|
| 149 |
Natalia Schneider Nunes, Saejeong Kim, Maggie Sundby, Parwathy Chandran, Scott Robert Burks, Ana Helena Paz, Joseph Alan Frank. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World Journal of Gastroenterology 2018; 24(38): 4341-4355 doi: 10.3748/wjg.v24.i38.4341
|
| 150 |
Mansi Patel, Bhagyabhumi Shah. Small Interfering Ribonucleic Acid (siRNA)-Based Therapeutics in Inflammatory Bowel Disease: Crosstalk between Immune Modulation and Epithelial Barrier Restoration. ACS Pharmacology & Translational Science 2026; 9(3) doi: 10.1021/acsptsci.5c00787
|
| 151 |
Jia Zhu, Tao Zhu, Caixia Sheng, Tingting Zhong, Jiaqi Xu, Xiaoqing Cheng, Jin Wang, Guoxiang Fu, Zhinong Jiang, Yujie Jiang. Intestinal CD8+ γδ T cells shift from immune activation to suppression, with concomitant impairment of cytotoxicity as disease activity increases in patients with ulcerative colitis. Central European Journal of Immunology 2025; doi: 10.5114/ceji.2025.153773
|
| 152 |
Lívia Bitencourt Pascoal, Bruna Biazon Palma, Fabio Henrique Mendonça Chaim, Marina Moreira de Castro, Tiago Andrade Damázio, Ana Paula Menezes de Freitas Franceschini, Marciane Milanski, Lício Augusto Velloso, Raquel Franco Leal. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World Journal of Experimental Medicine 2022; 12(1): 1-15 doi: 10.5493/wjem.v12.i1.1
|
| 153 |
Huajing Qiu, Xiaomin Sun, Mingming Sun, Chong He, Zhong Li, Zhanju Liu. Serum bacterial toxins are related to the progression of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2014; 49(7) doi: 10.3109/00365521.2014.919018
|
| 154 |
Yiling Zhu, Qing Zhao, Qi Huang, Yana Li, Jie Yu, Rui Zhang, Jiali Liu, Pupu Yan, Jinjin Xia, Liwei Guo, Guoping Liu, Xiaolin Yang, Jianguo Zeng. Nuciferine Regulates Immune Function and Gut Microbiota in DSS-Induced Ulcerative Colitis. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.939377
|
| 155 |
Phoebe Hodges, Paul Kelly. Inflammatory bowel disease in Africa: what is the current state of knowledge?. International Health 2020; 12(3) doi: 10.1093/inthealth/ihaa005
|
| 156 |
Pedro Palacios Argueta, Miguel Salazar, Bashar Attar, Roberto Simons-Linares, Bo Shen. 90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors. Inflammatory Bowel Diseases 2021; 27(4) doi: 10.1093/ibd/izaa224
|
| 157 |
Zbigniew Kmieć, Marta Cyman, Tomasz Jerzy Ślebioda. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Advances in Medical Sciences 2017; 62(1) doi: 10.1016/j.advms.2016.09.001
|
| 158 |
Kristina Pravoverov, Susmita Barman, Saiprasad Gowrikumar, Iram Fatima, Santosh Kumar Yadav, Megan Lynn Otte, Raju Lama Tamang, Mark Primeaux, Amar Bahadur Singh, Punita Dhawan. Tight Junctions in Inflammation and Cancer. 2023; doi: 10.1007/978-981-99-2415-8_1
|
| 159 |
Siba P. Raychaudhuri, Smriti K. Raychaudhuri. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Research & Therapy 2017; 19(1) doi: 10.1186/s13075-017-1249-5
|
| 160 |
Tyler Vunk, Kristin M. Burkholder. Modeling the Transmission and Prevention of Infectious Disease. Advances in Environmental Microbiology 2017; 4 doi: 10.1007/978-3-319-60616-3_4
|
| 161 |
Imteyaz Ahmad Khan, Sucharita Pilli, Surendranath A, Ritika Rampal, Sudhir Kumar Chauhan, Veena Tiwari, Venigalla Pratap Mouli, Saurabh Kedia, Baibaswata Nayak, Prasenjit Das, Govind K. Makharia, Vineet Ahuja, Leonardo A. Sechi. Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease. PLOS ONE 2016; 11(3) doi: 10.1371/journal.pone.0152063
|
| 162 |
Q. Zhang, X. Chen, S.D. Eicher, K.M. Ajuwon, T.J. Applegate. Effect of threonine on secretory immune system using a chicken intestinal ex vivo model with lipopolysaccharide challenge. Poultry Science 2017; 96(9) doi: 10.3382/ps/pex111
|
| 163 |
Zishao Tao, Li Li, Ying Zhang, Yufang Tang, Simeng Zhang, Heying Yang, Guorong Jiang, Rui Zhang, Zhiwei Wu, Miao He. The role of the tuft cell–interleukin-25 axis in the pathogenesis of inflammatory bowel disease. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1629060
|
| 164 |
Hui-Jun Tang, Cai-Qun Bie, Li-Liangzi Guo, Li-Xian Zhong, Shao-Hui Tang. Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine 2023; 25(6) doi: 10.3892/etm.2023.11997
|
| 165 |
Alejandro Bravo Iniguez, Min Du, Mei-Jun Zhu. α-Ketoglutarate for Preventing and Managing Intestinal Epithelial Dysfunction. Advances in Nutrition 2024; 15(4) doi: 10.1016/j.advnut.2024.100200
|
| 166 |
Xin Wen, Wei Li, Shifang Li, Dawei Chen, Junjie Zheng, Xia Wang, Cuiyu Zhang, Yanting Liu, Yao Ning, Ruinan Jia, Peng Li, Min Ji, Chunyan Ji, Jingxin Li, Wei Guo. Longitudinal single-cell RNA sequencing reveals a heterogeneous response of plasma cells to colonic inflammation. International Journal of Biological Macromolecules 2025; 294 doi: 10.1016/j.ijbiomac.2024.139307
|
| 167 |
Yaron Ilan. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clinical & Translational Immunology 2016; 5(1) doi: 10.1038/cti.2015.47
|
| 168 |
J. Claire Wilson, Raoul I. Furlano, Susan S. Jick, Christoph R. Meier. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases. Journal of Crohn's and Colitis 2016; 10(2) doi: 10.1093/ecco-jcc/jjv193
|
| 169 |
Yanmin Guo, Guangxi Zhou, Chong He, Wenjing Yang, Zhenkun He, Zhanju Liu, Marc Pouliot. Serum Levels of Lipopolysaccharide and 1,3‐β‐D‐Glucan Refer to the Severity in Patients with Crohn’s Disease. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/843089
|
| 170 |
Ian Woolveridge. In It for the Long Haul: Managing the Complexity of Crohn’s Disease. EMJ Gastroenterology 2016; doi: 10.33590/emjgastroenterol/10311197
|
| 171 |
Gretchen Harms Pritchard, Ross M. Kedl, Christopher A. Hunter. The evolving role of T-bet in resistance to infection. Nature Reviews Immunology 2019; 19(6) doi: 10.1038/s41577-019-0145-4
|
| 172 |
Rani Ahmad, Amr M. Ajlan, Ayman A. Eskander, Turki A. Alhazmi, Khalid Khashoggi, Mohammad A. Wazzan, Ahmed H. Abduljabbar. Magnetic resonance imaging in the management of Crohn’s disease: a systematic review and meta-analysis. Insights into Imaging 2021; 12(1) doi: 10.1186/s13244-021-01064-9
|
| 173 |
Ping Chen, Hua Zhu, Yujuan Mao, Mingxing Zhuo, Yali Yu, Min Chen, Qiu Zhao, Lianyun Li, Min Wu, Mei Ye. SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression. Journal of Gastroenterology and Hepatology 2021; 36(10) doi: 10.1111/jgh.15550
|
| 174 |
Esra Paydaş Hataysal, Muslu Kazım Körez, Eray Metin Guler, Hakan Vatansev, Kubra Bozalı, Metin Basaranoglu, Husamettin Vatansev. Impaired Kynurenine Pathway in Inflammatory Bowel Disease. Journal of Clinical Medicine 2024; 13(20) doi: 10.3390/jcm13206147
|
| 175 |
Ploutarchos Pastras, Ioanna Aggeletopoulou, Konstantinos Papantoniou, Christos Triantos. Targeting the IL-23 Receptor Gene: A Promising Approach in Inflammatory Bowel Disease Treatment. International Journal of Molecular Sciences 2025; 26(10) doi: 10.3390/ijms26104775
|
| 176 |
Joaquim Carreras, Giovanna Roncador, Rifat Hamoudi. Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks. Cancers 2024; 16(24) doi: 10.3390/cancers16244230
|
| 177 |
Yuling Fan, Wen Yi, Han Huang, Zhigang Mei, Zhitao Feng. Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis. Medicine 2019; 98(52) doi: 10.1097/MD.0000000000018512
|
| 178 |
Zhifeng Liu, Yi Jiao, Tianyuan Yu, Hourong Wang, Yingqi Zhang, Di Liu, Yajing Xu, Qian Guan, Mengqian Lu, Ying Li. A Review on the Immunomodulatory Mechanism of Acupuncture in the Treatment of Inflammatory Bowel Disease. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/8528938
|
| 179 |
Lorraine Oliveira-Cruz, Nayara Carvalho-Barbosa, Fabiana Cristina-Rodrigues, Thaís N. Côrtes, Kamila Guimarães-Pinto, André L. Amorim da Costa, Isadora S. de Lima, Talita G.B. Lourenço, Archimedes B. Castro-Junior, Alessandra D. Almeida Filardy, Ana Paula V. Colombo, Heitor S.P. de Souza, Christina M. Takiya, David M. Ojcius, Luiz Eduardo B. Savio, Robson Coutinho-Silva. Role of the P2X7 receptor in intestinal inflammation due to infection with the oral pathogen Porphyromonas gingivalis. Life Sciences 2025; 380 doi: 10.1016/j.lfs.2025.123971
|
| 180 |
Carlo Ronsini, Irene Iavarone, Eleonora Braca, Maria Giovanna Vastarella, Luigi Della Corte, Clorinda Vitale, Giada Andreoli, Elvira La Mantia, Luigi Cobellis, Pasquale de Franciscis. Deep Myometrial Infiltration leads to a measurable Inflammatory Response in Endometrial Cancer. A Prospective Observational Study. Seminars in Oncology 2024; 51(5-6) doi: 10.1053/j.seminoncol.2024.10.002
|
| 181 |
Rasakatla Dileep, Matukumalli Usharani, Boobalan Gopu, Alla Gopala Reddy, Matham Vijay Kuma, Chitturi Sree Venkat Satish Kum, Doppalapudi Madhuri. Ameliorative Effect of Ginger Extract in Acetic Acid Induced Ulcerative Colitis in Rats. Asian Journal of Animal and Veterinary Advances 2016; 11(2) doi: 10.3923/ajava.2016.130.136
|
| 182 |
Qingfeng Zhang, Xiaoyu Wu, Jingyi Wang, Jiahao Miao, Cunyin Li, Shangyong Li, Ningning He, Jingyi Song. The Role and Potential Mechanism of Pectin and Pectin Oligosaccharides in Treating Intestinal Inflammation by Regulating Gut Microbiota. Probiotics and Antimicrobial Proteins 2026; 18(4) doi: 10.1007/s12602-025-10839-1
|
| 183 |
Andrea Ardizzoni, Robert T. Wheeler, Eva Pericolini. It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.692491
|
| 184 |
Manoj Kumar, Mathieu Garand, Souhaila Al Khodor. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02174-1
|
| 185 |
Annie Luo, Steven T. Leach, Romain Barres, Luke B. Hesson, Michael C. Grimm, David Simar. The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00417
|
| 186 |
Danilo Pagliari, Giovanni Gambassi, Ciriaco A. Piccirillo, Rossella Cianci. The Intricate Link among Gut “Immunological Niche,” Microbiota, and Xenobiotics in Intestinal Pathology. Mediators of Inflammation 2017; 2017 doi: 10.1155/2017/8390595
|
| 187 |
Sujuan Ding, Hongmei Jiang, Jun Fang. Regulation of Immune Function by Polyphenols. Journal of Immunology Research 2018; 2018 doi: 10.1155/2018/1264074
|
| 188 |
Elliott T J Dunn, Edward S Taylor, Simon Stebbings, Michael Schultz, A Grant Butt, Roslyn A Kemp. Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunology & Cell Biology 2016; 94(5) doi: 10.1038/icb.2015.112
|
| 189 |
Helal F. Hetta, Yasmin N. Ramadan, Ahmad A. Alharbi, Shomokh Alsharef, Tala T. Alkindy, Alanoud Alkhamali, Abdullah S. Albalawi, Hussein El Amin. Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy. Immuno 2024; 4(4) doi: 10.3390/immuno4040026
|
| 190 |
Anderson dos Santos Ramos, Giovana Cristina Santana Viana, Marcelo de Macedo Brigido, Juliana Franco Almeida. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacological Research 2021; 171 doi: 10.1016/j.phrs.2021.105779
|
| 191 |
Rayna Shentova-Eneva, Ivan Yankov. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022; doi: 10.5772/intechopen.102226
|
| 192 |
Enas A. M. Huseein, Samia S. Alkhalil, Hanan S. M. Farghaly, Haiam M. M. Farrag, Hanaa Y. Bakir, Noha M. Aboulhagag, Samah S. M. Mohamed, Mona Gaber. Protective and therapeutic potentials of Trichinella spiralis larval antigen in murine induced colitis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-13229-3
|
| 193 |
Gabriela Fonseca-Camarillo, Jesús K. Yamamoto-Furusho. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(9) doi: 10.1097/MIB.0000000000000477
|
| 194 |
Liping Guan, Hankui Liu, Ningjing Zhao, Hairui Sun, Lijian Zhao, Jianguo Zhang, Qing Shu. Polygenic risk scores for Crohn’s disease risk prediction in a Chinese population: insights from multi-ethnic genome-wide association studies. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-03838-7
|
| 195 |
Claudia Deutschmann, Mandy Sowa, Jayaseelan Murugaiyan, Uwe Roesler, Nadja Röber, Karsten Conrad, Martin W Laass, Dimitrios Bogdanos, Nora Sipeki, Maria Papp, Stefan Rödiger, Dirk Roggenbuck, Peter Schierack. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s Disease. Journal of Crohn's and Colitis 2019; 13(7) doi: 10.1093/ecco-jcc/jjz012
|
| 196 |
Takayuki Shimada, Naoyoshi Nagata, Koki Okahara, Akane Joya, Tsunefusa Hayashida, Shinichi Oka, Toshiyuki Sakurai, Junichi Akiyama, Naomi Uemura, Hiroyuki Gatanaga, Leonid Margolis. PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection. PLOS ONE 2017; 12(9) doi: 10.1371/journal.pone.0184699
|
| 197 |
Andrea Ardizzoni, Arianna Sala, Bruna Colombari, Lavinia Beatrice Giva, Claudio Cermelli, Samuele Peppoloni, Anna Vecchiarelli, Elena Roselletti, Elisabetta Blasi, Robert T. Wheeler, Eva Pericolini. Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis. Journal of Fungi 2020; 6(4) doi: 10.3390/jof6040225
|
| 198 |
Horacio L.R. Rilo, Joaquin Cagliani, Daniel Grande, Ernesto P Molmenti, Edmund J. Miller. Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications. Journal Of Stem Cell & Regenerative Biology 2017; 3(2) doi: 10.15436/2471-0598.17.022
|
| 199 |
G. V. Volynets, A. V. Nikitin, T. A. Skvortsova, A. S. Potapov, V. V. Dudurich, L. G. Danilov. Gut microbiota in chronic liver diseases in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2023; 68(2) doi: 10.21508/1027-4065-2023-68-2-69-73
|
| 200 |
A. V. Nikitin, G. V. Volynets, A. S. Potapov, V. V. Dudurich, L. G. Danilov. Comparative assessment of intestinal microbiota in autoimmune and non-autoimmune liver diseases in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2024; 69(1) doi: 10.21508/1027-4065-2024-69-1-58-65
|
| 201 |
Sagun Poudel, Prabhat R. Napit, Karen P. Briski, George Mattheolabakis. Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers. Pharmaceutics 2021; 13(7) doi: 10.3390/pharmaceutics13071075
|
| 202 |
Lauren O'Connell, Des C. Winter, Carol M. Aherne. The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.624045
|
| 203 |
Deepavali Chakravarti, Rumi Lee, Asha S. Multani, Andrea Santoni, Zachery Keith, Wen-Hao Hsu, Kyle Chang, Laura Reyes, Asif Rashid, Chang-Jiun Wu, Jun Li, Jiexin Zhang, Hong Seok Shim, Krishna Chandra, Pingna Deng, Denise J. Spring, Ole Haagen Nielsen, Lene Buhl Riis, Kavya Kelagere Mayigegowda, Sarah E. Blutt, Jianhua Zhang, Mamoun Younes, Andrew DuPont, Selvi Thirumurthi, Eduardo Vilar, Mary K. Estes, Simona Colla, Noah F. Shroyer, Ronald A. DePinho. Telomere dysfunction instigates inflammation in inflammatory bowel disease. Proceedings of the National Academy of Sciences 2021; 118(29) doi: 10.1073/pnas.2024853118
|
| 204 |
Jessica Stockheim, Mikhael Belkovsky, Lukas Schabl, Stefan D. Holubar, Scott R. Steele, Tracy Hull, Hermann Kessler. Endometriosis and its role in pouch patients: A matched‐pair analysis. Colorectal Disease 2025; 27(8) doi: 10.1111/codi.70183
|
| 205 |
Chensijin Sun, Luyun Zhang, Mengting Zhang, Jianxin Wang, Shaoya Rong, Wei Lu, Hui Dong. Zinc pyrithione induces endothelium-dependent hyperpolarization-mediated mesenteric vasorelaxation in healthy and colitic mice. Biochemical Pharmacology 2023; 217 doi: 10.1016/j.bcp.2023.115828
|
| 206 |
Heba A. Hassan, Amira Mohamed abdelhamid, Walaa Samy, Heba Osama Mohammed, Samar Mortada Mahmoud, Amal fawzy abdel mageed, Noha A.T. Abbas. Ameliorative effects of androstenediol against acetic acid-induced colitis in male wistar rats via inhibiting TLR4-mediated PI3K/Akt and NF-κB pathways through estrogen receptor β activation. International Immunopharmacology 2024; 127 doi: 10.1016/j.intimp.2023.111414
|
| 207 |
Suprabhat Mukherjee, Nikhilesh Joardar, Subhasree Sengupta, Santi P. Sinha Babu. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. The Journal of Nutritional Biochemistry 2018; 61 doi: 10.1016/j.jnutbio.2018.07.010
|
| 208 |
Juan Liu. RETRACTED: Aged garlic therapeutic intervention targeting inflammatory pathways in pathogenesis of bowel disorders. Heliyon 2024; 10(14) doi: 10.1016/j.heliyon.2024.e33986
|
| 209 |
Kawthar Braysh, Alice Gerges Geagea, Charbel Matar, Manfredi Rizzo, Assaad Eid, Liliane Massaad-Massade, Samir Mallat, Abdo Jurjus. Kidney Manifestations of Inflammatory Bowel Diseases. Open Journal of Gastroenterology 2018; 8(05) doi: 10.4236/ojgas.2018.85020
|
| 210 |
Ibrahim Habib, Andrew Mazulis, Grigory Roginsky, Eli D. Ehrenpreis. Nonsteroidal Anti-inflammatory Drugs and Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(12) doi: 10.1097/MIB.0000000000000165
|